Her Royal Highness Princess Dina Mired shared a post on LinkedIn:
“Why Independent Clinical Research Matters
On Global Health Dialogues, Princess Dina Mired and Denis Lacombe, CEO of EORTC and a global leader in independent cancer research, explore how independent clinical research answers the critical questions that industry-led trials often do not, such as how treatments compare in real life, how to reduce toxicity, and how cancer care affects quality of life and survivorship.
By reducing bias, strengthening trust in evidence, and expanding research to populations and regions long excluded from clinical trials, independent research helps ensure that innovation translates into equitable, effective, and patient-centered care for all.
A clear look at why non profit evidence is essential to move cancer care forward.
Watch the episode here.”